Arca Biopharma
Biotechnology, Church Ranch Way Ste 100, Westminster, , 80021, Colorado, 10170, United States, 11-50 Employees
Phone Number: 72********
Who is ARCA BIOPHARMA
ARCA was founded on the belief that a precision medicine approach to drug development, tailoring medical treatment to the individual genetic characteristics of patients, can enable more e...
Read More
-
Headquarters: 10170 Church Ranch Way Ste 100, Westminster, Colorado, 80021, United States
-
Date Founded: 1992
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from ARCA BIOPHARMA
ARCA biopharma Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding ARCA biopharma
Answer: ARCA biopharma's headquarters are located at Church Ranch Way Ste 100, Westminster, , 80021, Colorado, 10170, United States
Answer: ARCA biopharma's phone number is 72********
Answer: ARCA biopharma's official website is https://arcabio.com
Answer: ARCA biopharma's revenue is $1 Million to $5 Million
Answer: ARCA biopharma's SIC: 2834
Answer: ARCA biopharma's NAICS: 325412
Answer: ARCA biopharma has 11-50 employees
Answer: ARCA biopharma is in Biotechnology
Answer: ARCA biopharma contact info: Phone number: 72******** Website: https://arcabio.com
Answer: ARCA was founded on the belief that a precision medicine approach to drug development, tailoring medical treatment to the individual genetic characteristics of patients, can enable more effective therapies, improve patient outcomes and reduce healthcare costs. ARCA’s lead development program is intended to be a direct implementation of those ideas. Gencaro™ (bucindolol hydrochloride) is being developed as a potential treatment for atrial fibrillation (AF). ARCA has identified genetic variations in cardiac receptors that we believe may predict individual patient response to Gencaro™, giving Gencaro™ the potential to be the first genetically-targeted prevention treatment for AF. ARCA is also developing rNAPc2 as potential treatment for RNA-associated diseases, initially focused on COVID-19.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month